|
MedChemExpress
abacavir Abacavir, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/Abacavir/pm42320113-67-3-4 Average 94 stars, based on 1 article reviews
abacavir - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
hy 13238 lamivudine 3tc bei resources hrp 8146 abacavir abc Hy 13238 Lamivudine 3tc Bei Resources Hrp 8146 Abacavir Abc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/Dolutegravir/pm42224077-90-133-132 Average 94 stars, based on 1 article reviews
hy 13238 lamivudine 3tc bei resources hrp 8146 abacavir abc - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Videx Inc
abacavir lamivudine zidovudine Abacavir Lamivudine Zidovudine, supplied by Videx Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/abacavir+lamivudine+zidovudine/us12622971-153-90-99 Average 86 stars, based on 1 article reviews
abacavir lamivudine zidovudine - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
MedChemExpress
abc Abc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/Abacavir/pm41904696-60-18-19 Average 94 stars, based on 1 article reviews
abc - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
3tc ![]() 3tc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/Abacavir/pmc13034632-56-21-22 Average 94 stars, based on 1 article reviews
3tc - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Gilead Sciences
abc ziagen ![]() Abc Ziagen, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/Emtriva/us12570626-966-21-22 Average 99 stars, based on 1 article reviews
abc ziagen - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
|
Shanghai Aladdin Bio-Chem
abacavir ![]() Abacavir, supplied by Shanghai Aladdin Bio-Chem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/abacavir/abacavir/pm41806576-49-0-5 Average 86 stars, based on 1 article reviews
abacavir - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
Journal: ASN NEURO
Article Title: Exposure to Frontline Antiretroviral Dolutegravir Disrupts Oligodendrocyte Development Across Differentiation Stages
doi: 10.1080/17590914.2026.2647877
Figure Lengend Snippet: Multistage exposure to increasing doses of DTG+ABC + 3TC inhibits OL maturation. (a) Diagram of multistage treatment paradigm with DTG+ABC + 3TC during OPC proliferation and OL differentiation. (b) Representative images of differentiated OLs after multistage treatment with DTG+ABC + 3TC and immunostained for GalC (green), PLP (red), and DAPI (blue). Scale bar = 75 µm. Quantification of the number of GalC + (c) and PLP + (d) cells shows significantly fewer differentiated OLs after multistage exposure to DTG+ABC + 3TC without an effect on total number of DAPI + cells (e), n = 3/group. f) Representative immunoblots of MBP and PLP after multistage exposure to DTG+ABC + 3TC. Densitometry analyses show significantly less MBP (g) and PLP (h) expression, n = 3/group. One-way ANOVA with Dunnett post-hoc test to compare all treatment groups to DMSO. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Article Snippet: In this study, OPCs were treated with the antiretroviral drugs DTG (Toronto Research Chemicals, D528800 and MedChemExpress, HY-13238), ABC (MedChemExpress, HY-17423),
Techniques: Western Blot, Expressing
Journal: ASN NEURO
Article Title: Exposure to Frontline Antiretroviral Dolutegravir Disrupts Oligodendrocyte Development Across Differentiation Stages
doi: 10.1080/17590914.2026.2647877
Figure Lengend Snippet: DTG, but not ABC or 3TC, significantly impairs OL maturation after multistage exposure. (a) Representative images of differentiated OLs after multistage treatment with DTG, ABC, or 3TC and immunostained for GalC (green), PLP (red), and DAPI (blue). Scale bar = 75 µm. Quantification of the number of GalC + and PLP + cells shows significantly fewer differentiated OLs without a change in DAPI after multistage exposure to DTG (b-d) but not ABC (e-g) or 3TC (h-j), n = 3/group. One-way ANOVA with Dunnett post-hoc test to compare all treatment groups to DMSO. ** p < 0.01, **** p < 0.0001.
Article Snippet: In this study, OPCs were treated with the antiretroviral drugs DTG (Toronto Research Chemicals, D528800 and MedChemExpress, HY-13238), ABC (MedChemExpress, HY-17423),
Techniques:
Journal: ASN NEURO
Article Title: Exposure to Frontline Antiretroviral Dolutegravir Disrupts Oligodendrocyte Development Across Differentiation Stages
doi: 10.1080/17590914.2026.2647877
Figure Lengend Snippet: DTG, but not ABC or 3TC, significantly reduces myelin protein expression after multistage exposure. (a) Representative immunoblots of MBP and PLP after multistage exposure to DTG (800 nM, 8 µM, or 24 µM). Densitometry analyses show significantly less MBP after exposure to 800 nM, 8 µM, or 24 µM DTG (b) and PLP after exposure to 24 µM DTG (c), n = 3/group. (d) Representative immunoblots of MBP and PLP after multistage exposure to ABC (150 nM, 1.5 µM, or 4.5 µM). Densitometry analyses show no changes in MBP (e) or PLP (f) expression, n = 3/group. g) Representative immunoblots of MBP and PLP after multistage exposure to 3TC (600 nM, 6 µM, or 18 µM). Densitometry analyses show no changes in MBP (h) or PLP (i) expression, n = 3/group. One-way ANOVA with Dunnett post-hoc test to compare all treatment groups to DMSO. ** p < 0.01, **** p < 0.0001.
Article Snippet: In this study, OPCs were treated with the antiretroviral drugs DTG (Toronto Research Chemicals, D528800 and MedChemExpress, HY-13238), ABC (MedChemExpress, HY-17423),
Techniques: Expressing, Western Blot